,20,21 In a small study, incorporating DAC into lymphodepletion significantly improved response durability, resulting in longer PFS and OS in patients with B-ALL receiving CD19/CD22 CAR T cells.22 This evidence concerns the gene CD19 and precursor B-cell acute lymphoblastic leukemia.